Alzheimer's Prevention Initiative Generation Study 2 (GS2) Data Use Agreement
Access is requested for scientific investigation, teaching or planning clinical research. The request is passed to the Generation Program team, which follows up with further steps, and approved requests need a formally executed Data Transfer Agreement whose terms are not published.
Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer
What you can do
- Not stated
- Not stated
- Not stated
- Not stated
- Not stated
What you can share
- Not stated
- Not stated
- Not stated
What you must do
- Not stated
- Share alike No
- Yes
- Not stated
- Not stated
- Release code No
- Not stated
- Not stated
Limits
- Not stated
- Location limits No
Separate commercial license: Not stated No commercial license offer is published.
Datasets under this license
- API Generation Study 2 (GS2)
Brain MRI (safety, volumetric and resting-state functional) and amyloid and tau PET from a prevention trial of the BACE1 inhibitor umibecestat in cognitively unimpaired APOE4 carriers aged 60 to 75. 1145 participants randomized at sites in 25 countries.